Caravan Biologix is focused on rare and hard treat human diseases. Our mission is to develop
state of the art therapeutics to make a genuine difference.
Caravan Biologix is focused on rare and hard treat human diseases. Our mission is to develop
state of the art therapeutics to make a genuine difference.
Caravan Biologix is focused on rare and hard treat human diseases. Our mission is to develop
state of the art therapeutics to make a genuine difference.
Mini-CAR Pre-Clinical Development Pipeline
CAR001
Undisclosed Carcinoma
CAR002
Undisclosed Sarcoma
CAR003
Undisclosed Hereditary Disease
CAR001
Represents a revolutionary approach to solid tumor treatment through their unique design and delivery system. Our AI-engineered BioSpheres combine enhanced tissue penetration with precision targeting capabilities, enabling them to effectively reach and eliminate carcinoma cells while preserving surrounding healthy tissue. This dual mechanism of improved tumor access and selective killing offers patients a potentially safer and more effective treatment option.
CAR002
May offer unprecedented tumor penetration and killing power in the context of sarcomas, both bone and soft tissue variants. These BioSpheres, armed with CARs, are designed to target sarcoma cells with remarkable specificity, reducing damage to healthy tissue while minimizing side effects in these challenging mesenchymal malignancies.
CAR003
Has exceptional promise in restoring cellular functions in several hereditary diseases. These specialized BioSpheres can precisely target and release therapeutic payloads to dysfunctional cells, enhancing their activity against their dysregulated immune repsonses.